Fundraising Fox

Ombu Group

Growth equity

London · Growth–Late Stage · 8 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Ombu concentrates its resources on a small, focused portfolio of advanced environmental technology companies in which it takes substantial ownership stakes. Rather than building large portfolios of potential businesses, the firm emphasizes deep strategic and operational support, placing experienced business leaders at board level to help management teams succeed. It aims to build durable, scalable, sustainable businesses and takes a genuinely long-term approach, recognizing that advanced technology businesses take considerable time to mature. This concentrated, hands-on philosophy is what the firm presents as differentiating it from typical venture and growth-stage investors.

Invests inCleantechClimate TechDeep TechEnergyHealthtechEuropeLondonUnited Kingdom

Source: firm website, verified Aug 2, 2026.

Stage
Growth–Late Stage
HQ
London, GB
Instruments
Equity
Tracked investments
1

Team · 8 people

from the firm's website
Stephen Brooke· Chief Executive Officer

Founder of Ombu with over twenty years of investment experience. Previously founded and led Swarraton Partners and was Director of Business Development at IP Group plc; sits on the boards of P2i and Bluewater Bio.

Duncan White· Investment Director

Experienced in developing and financing advanced technologies in industrial, energy and healthcare sectors. Previously worked in M&A at Rothschild Group and holds a PhD in Chemistry from Cambridge; sits on the board of Iceotope.

Chris Saunders· Executive Chairman, P2i

CEO and entrepreneur who was VP of Actaris Metering Systems (exited to Itron for €1.8bn), founder and CEO of Navetas Energy Management, and led the UK trade association BEAMA.

Madeleine Bonieux· Chief Financial Officer and Company Secretary

Leads Ombu's finance function, audit, reporting and operations, providing administrative and legal support. She is an ICAEW Chartered Accountant with a corporate governance diploma from the Governance Institute of Australia.

Richard Haddon· Executive Chairman, Bluewater Bio

Experienced leader in the utility and support services sectors, having held senior roles at British Gas, National Grid and Transco and CEO positions at Fulcrum Connections and Fountains plc.

Sir John Parker· Strategic Advisor

Experienced business leader who has chaired five FTSE 100 companies, currently non-executive chairman of Laing O'Rourke and Pennon Group, with prior chairmanships at Anglo American and National Grid.

Sir John Rose· Non-Executive Chairman

Former Chief Executive of Rolls-Royce Group plc (1996-2011), Deputy Chairman of Rothschild Continuation Holdings, and a board/advisory member at BW Group, Hambro Perks and other organizations.

Tom Bradley· Non-Executive Director

Partner at Hambro Perks with twenty years of startup investing experience. Previously CEO and Managing Partner of Oxford Capital and held leadership roles at DN Capital and Draper Esprit.

Investments · 1 tracked

founders shown can be your intro path
Phase Focus

Computational imaging technology and live cell analysis system

Frequently asked questions

What stage does Ombu Group invest at?
Ombu Group invests at the Growth, Late Stage stages.
What sectors does Ombu Group focus on?
Ombu Group focuses on Cleantech, Climate Tech, Deep Tech, Energy, Healthtech.
Where is Ombu Group located?
Ombu Group is headquartered in London, GB.

Similar investors

Featured in lists